CHLOE HELLER: Open Payments
NPI 1982470308 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,596 in 89 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $740 · 2025 $1,596
Food & beverage: $1,432Education: $164
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $295 |
| Janssen Biotech, Inc. | 21 | $295 |
| Regeneron Healthcare Solutions, Inc. | 6 | $203 |
| Incyte Corporation | 17 | $189 |
| GENZYME CORPORATION | 4 | $182 |
| Organon LLC | 5 | $135 |
| UCB, Inc. | 3 | $71 |
| Novartis Pharmaceuticals Corporation | 2 | $55 |
| Galderma Laboratories, L.P. | 2 | $40 |
| Almirall LLC | 1 | $33 |
Products named: DUPIXENT, TREMFYA, OPZELURA, RINVOQ, SKYRIZI, VTAMA, Bimzelx, Rhapsido.
Industry payments across PA — which companies pay providers there.
